Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 581.02Cr 86Cr 75Cr 69Cr 64Cr 121.16Cr 8.17TCr 123.2Cr 826.05Cr 324.39Cr 4.03TCr 321.74Cr 314.74Cr 14TCr P/E 2026 *
10.8x
P/E 2027 * 9.1x
Enterprise Value 447.05Cr 66Cr 58Cr 53Cr 49Cr 93Cr 6.29TCr 95Cr 635.58Cr 249.59Cr 3.1TCr 247.56Cr 242.17Cr 11TCr EV / Sales 2026 *
0.25x
EV / Sales 2027 * 0.22x
Free-Float
51.88%
Yield 2026 *
4.68%
Yield 2027 * 5.28%
1 day+0.70%
1 week-2.32%
Current month+5.53%
1 month-6.56%
3 months-19.43%
6 months-23.91%
Current year-21.31%
1 week 9.9
Extreme 9.9
10.52
1 month 9.41
Extreme 9.41
11.29
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
16.68
3 years 9.41
Extreme 9.41
26.96
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap.
12/05Buy

Founder

13,59,000 0.3397%
12/05Sell

Founder

-27,27,600 0.6818%
11/05Sell

Founder

-88,06,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+0.70%-2.32%-37.57%-60.00% 86Cr
+2.19%+3.32%-12.44%-27.01% 1.52TCr
+2.06%+5.47%-20.59%-28.31% 715.47Cr
-2.75%+0.77%-22.15%-9.08% 590.12Cr
-0.15%+0.75%-17.78%-34.07% 359.58Cr
+0.60%-5.66%-36.88%-12.40% 322.78Cr
+0.54%-1.70%-28.37%-48.32% 318.19Cr
0.00%+3.52%+3.95%-36.24% 296.45Cr
-0.24%-2.48%+100.78% - 259.36Cr
-2.03%-0.29%-21.45%-3.72% 245.06Cr
Average +0.09%-0.18%-9.25%-28.79% 471.26Cr
Weighted average by Cap. +0.63%+1.45%-11.71%-25.84%

Financials

2026 *2027 *
Net sales 1.8TCr 266.17Cr 232.82Cr 214.75Cr 198.34Cr 376.34Cr 25TCr 382.67Cr 2.57TCr 1.01TCr 13TCr 999.39Cr 977.65Cr 43TCr 1.92TCr 282.56Cr 247.15Cr 227.97Cr 210.55Cr 399.51Cr 27TCr 406.23Cr 2.72TCr 1.07TCr 13TCr 1.06TCr 1.04TCr 46TCr
Net income 55Cr 8.04Cr 7.03Cr 6.49Cr 5.99Cr 11Cr 766.77Cr 12Cr 78Cr 30Cr 377.73Cr 30Cr 30Cr 1.3TCr 65Cr 9.58Cr 8.38Cr 7.73Cr 7.14Cr 14Cr 913.82Cr 14Cr 92Cr 36Cr 450.18Cr 36Cr 35Cr 1.55TCr
Net Debt -133.97Cr -20Cr -17Cr -16Cr -15Cr -28Cr -1.88TCr -28Cr -190.47Cr -75Cr -928.34Cr -74Cr -73Cr -3.19TCr -163.03Cr -24Cr -21Cr -19Cr -18Cr -34Cr -2.29TCr -35Cr -231.79Cr -91Cr -1.13TCr -90Cr -88Cr -3.88TCr
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
10/26/10 CN¥10.12 +0.70% 65,70,582
09/26/09 CN¥10.05 -2.33% 59,03,393
08/26/08 CN¥10.29 +0.98% 55,12,525
07/26/07 CN¥10.19 -2.49% 63,70,700
06/26/06 CN¥10.45 +0.87% 85,40,589
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
10.12CNY
Average target price
14.86CNY
Spread / Average Target
+46.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock